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Mycobacterium tuberculosis is a bacterium responsible for thousands of deaths worldwide [1]. 
Its acquired resistance referred to multi-drug resistance (MDR) is due to the restrictive choice 
of antibiotics, the prolonged course of therapy, globalization and continuous patient 
noncompliance [2]. Hence, MDR tuberculosis has led researchers worldwide in the quest to 
find novel drugs to combat these threatening new strains.   
  
In our research group, 6-imidatopurines of general structure 1 (Figure 1) were identified as 
precursors to generate 6-amidinopurines of general structure 2 (Scheme 1) [3,4]. When 
reacting compounds of structure 1 with a selected hydrazide a (Scheme 1) in the 
experimental conditions established by our research group, compounds with structure 2 are 
promptly obtained. 
  
When the same reaction conditions were used with benzylhydrazine to obtain products 2 
(Scheme 1) an unexpected new derivative was isolated. The proton NMR spectrum of the 
new derivative showed the absence of the alkyl moiety. Furthermore, the data was not 
compatible with the purine nucleus. The HMBC and HMQC data showed that the new 
compound contained the pyrimidopyrimidine core. 
 
All the results will be shown and a possible mechanistic approach will be presented and 
discussed in order to understand the formation of the new derivative. 
 
 
Figure 1 
Scheme 1. 
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